FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Morton Grove Pharmaceuticals Prednisolone Sodium Phosphate Oral Solution Recall

Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, packaged in a 8 fl oz (237 mL)…

Morton Grove Pharmaceuticals, Inc. · Morton Grove, IL

Risk level
Class II
Reported by FDA
Oct 16, 2019
Recall ID
D-0130-2020
Check your lot numberHow we source this data

Summary

Morton Grove Pharmaceuticals recalled Prednisolone Sodium Phosphate Oral Solution starting Sep 23, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0130-2020 on Oct 16, 2019. Reason: Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14

Product description

Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, packaged in a 8 fl oz (237 mL) bottle, Rx only, Manufactured By Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053. NDC 60432-212-08

Lot numbers, UPCs & expiration codes

Lot #: US1450, Exp 10/31/19; US1570, Exp 12/31/19; UT1018, Exp 1/31/19; UT1173, Exp 6/30/20; UT1348, UT1354, Exp 8/31/20

Where it was sold

Nationwide USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0130-2020
Classification
Class II
Status
Terminated
Recall initiated
Sep 23, 2019
FDA report date
Oct 16, 2019
Quantity
196,408 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Morton Grove Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0130-2020, exactly as published.

Show all FDA fields
City
Morton Grove
State
IL
Status
Terminated
Country
United States
Event ID
83858
Address
6451 Main St
Code information
Lot #: US1450, Exp 10/31/19; US1570, Exp 12/31/19; UT1018, Exp 1/31/19; UT1173, Exp 6/30/20; UT1348, UT1354, Exp 8/31/20
Postal code
60053-2633
Report date
Oct 16, 2019
Product type
Drugs
Recall number
D-0130-2020
Classification
Class II
Recalling firm
Morton Grove Pharmaceuticals, Inc.
Product quantity
196,408 bottles
Termination date
Sep 24, 2022
Reason for recall
Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14
Voluntary / mandated
Voluntary: Firm initiated
Product description
Prednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, packaged in a 8 fl oz (237 mL) bottle, Rx only, Manufactured By Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053. NDC 60432-212-08
Distribution pattern
Nationwide USA and Puerto Rico
Recall initiation date
Sep 23, 2019
Initial firm notification
Letter
Center classification date
Oct 8, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0130-2020, published Oct 16, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls